Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Mouse pluripotent stem cell line for erythroid specific high-expression GFP (Green Fluorescent Protein) and construction method of mouse pluripotent stem cell line

A pluripotent stem cell, high-expression technology, applied in the field of induced stem cells, can solve the problems of inconsistent copy number of transgenes, silencing of inserted gene expression, and inability to fully achieve directional integration.

Inactive Publication Date: 2019-01-11
SHANGHAI CHILDRENS HOSPITAL +1
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the commonly used transgenic technology cannot fully achieve directional integration, and the copy number of the integrated gene cannot be effectively controlled, which leads to differences in the expression of exogenous genes among transgenic mice and among the offspring of transgenic mice
[0004] Conventional transgenic embryonic stem cells directly introduce exogenous genes into ESCs. This method often results in random insertion of exogenous genes, inconsistencies in the copy number of transgenes in each cell clone, and expression silencing of inserted genes.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Mouse pluripotent stem cell line for erythroid specific high-expression GFP (Green Fluorescent Protein) and construction method of mouse pluripotent stem cell line
  • Mouse pluripotent stem cell line for erythroid specific high-expression GFP (Green Fluorescent Protein) and construction method of mouse pluripotent stem cell line
  • Mouse pluripotent stem cell line for erythroid specific high-expression GFP (Green Fluorescent Protein) and construction method of mouse pluripotent stem cell line

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] The preparation method of the chimera mouse with specific high expression of GFP in the erythroid line is carried out according to the following steps:

[0019] (1) For HG Kunming white transgenic mice, the operation steps refer to the technical method of Richa.

[0020] (2) Preparation of HG ES cells:

[0021] Refer to the ESCs preparation technique of Bryja et al. Because hybrid ESCs are more capable of giving birth to germline chimeric mice. Therefore, HG Kunming white transgenic mice were mated with C57 mice, and the offspring HG male mice were mated with C57 female mice, and the 3.5-day-old blastocysts were used to inoculate MEF cells treated with mitomycin. HG ES cell primary FBS medium: 20% FBS For ES+1% NEAA+1% Pen Strep+1% L-Glutamine+0.1%2-Mercaptoethanol+2000IU / ml LIF+DMEM; HG ES cell primary SR culture Base: 20% SR + 1% NEAA + 1% Pen Strep + 1% L-Glutamine + 0.1% 2-Mercaptoethanol + 2000IU / ml LIF + DMEM; HG ES cell expansion medium: HG ES cell primary SR ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a mouse pluripotent stem cell line for an erythroid specific high-expression GFP (Green Fluorescent Protein) and a construction method of the mouse pluripotent stem cell line.The mouse pluripotent stem cell line is prepared by the following steps: injecting an erythroid high-expression GFP vector into male pronucleus of Kunming white mouse fertilized eggs in a micro-injection manner, cultivating transgenic mice, verifying expressions of inserted genes at specific tissue cells, reproducing the transgenic mice, stabilizing the copy number of exogenous genes of generationmice of the transgenic mice, and preparing the mouse pluripotent stem cell line by blastaea. The mouse pluripotent stem cell line disclosed by the invention has important cytological value for researching in-vivo and in-vitro formation and evolution of blood cells, which contributes to uncovering the hematopoietic stem formation and complicated influence effect of the hematopoietic microenvironment and pushing the research process of differentiating pluripotent stem cells to transplantable hematopoietic stem cells in vitro.

Description

technical field [0001] The invention belongs to the technical field of induced stem cells, and in particular relates to a mouse pluripotent stem cell line with erythroid-specific high expression of GFP and a construction method thereof. Background technique [0002] The first mouse transgenic embryonic stem cells (ESCs) were obtained in 1981. ESCs have self-renewal and multi-directional differentiation potential. It has been confirmed that ESCs can differentiate into all tissue cells by using tetraploid compensation technology. In terms of in vitro differentiation, researchers have successfully induced ESCs to form pancreatic cells, nerve cells, cardiomyocytes, and hematopoietic cells. Stem cells and other tissue cells. These characteristics of ESCs have promoted the research of functional genes. ESCs carrying specific exogenous genes can study the basic functions and regulatory mechanisms of genes in vivo and in vitro, and can develop molecular biological farms to explore...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/10C12N15/85A01K67/027
CPCA01K67/0275C12N5/0696C07K14/43595A01K2227/105
Inventor 曾凡一黄淑帧杨冠恒曾溢滔
Owner SHANGHAI CHILDRENS HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products